NCT06414694View on ClinicalTrials.gov

Inpatient Penicillin Delabeling for Low-Risk Patients

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions
PenicillinDrug Allergy
Interventions
PROCEDURE

Direct Oral Challenge

Direct oral challenge to penicillin at a goal dose of 45 mg/kg given in a 10%/90% dose

Trial Locations (1)

38163

University of Tennessee Health Science Center, Memphis

All Listed Sponsors
lead

University of Tennessee

OTHER